SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-068016
Filing Date
2022-03-07
Accepted
2022-03-07 16:31:43
Documents
5
Effectiveness Date
2022-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 d305613ds8.htm S-8 45221
2 EX-5.1 d305613dex51.htm EX-5.1 9689
3 EX-23.2 d305613dex232.htm EX-23.2 1575
4 EX-FILING FEES d305613dexfilingfees.htm EX-FILING FEES 23194
5 GRAPHIC g305613g0307094747817.jpg GRAPHIC 4427
  Complete submission text file 0001193125-22-068016.txt   87079
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263343 | Film No.: 22718496
SIC: 2834 Pharmaceutical Preparations